Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Oct 1;89(19):9297–9301. doi: 10.1073/pnas.89.19.9297

Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.

E Natt 1, K Kida 1, M Odievre 1, M Di Rocco 1, G Scherer 1
PMCID: PMC50113  PMID: 1357662

Abstract

Tyrosinemia type II (Richner-Hanhart syndrome, RHS) is a disease of autosomal recessive inheritance characterized by keratitis, palmoplantar hyperkeratosis, mental retardation, and elevated blood tyrosine levels. The disease results from deficiency in hepatic tyrosine aminotransferase (TAT; L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5), a 454-amino acid protein encoded by a gene with 12 exons. To identify the causative mutations in five TAT alleles cloned from three RHS patients, chimeric genes constructed from normal and mutant TAT alleles were tested in directing TAT activity in a transient expression assay. DNA sequence analysis of the regions identified as nonfunctional revealed six different point mutations. Three RHS alleles have nonsense mutations at codons 57, 223, and 417, respectively. One "complex" RHS allele carries a GT----GG splice donor mutation in intron 8 together with a Gly----Val substitution at amino acid 362. A new splice acceptor site in intron 2 of the fifth RHS allele leads to a shift in reading frame.

Full text

PDF
9297

Images in this article

9298Image
on p.9298
9299Image
on p.9299
9300Image
on p.9300
9300Image
on p.9300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson S. M. Induction of cytosolic tyrosine aminotransferase by dexamethasone in organ culture of fetal human liver. Early Hum Dev. 1982 Apr;6(2):165–169. doi: 10.1016/0378-3782(82)90104-9. [DOI] [PubMed] [Google Scholar]
  2. Andersson S. M., Pispa J. P. Purification and properties of human liver tyrosine aminotransferase. Clin Chim Acta. 1982 Oct 27;125(2):117–123. doi: 10.1016/0009-8981(82)90188-7. [DOI] [PubMed] [Google Scholar]
  3. Andersson S. M., Räihä N. C., Ohisalo J. J. Tyrosine aminotransferase activity in human fetal liver. J Dev Physiol. 1980 Feb-Apr;2(1-2):17–27. [PubMed] [Google Scholar]
  4. Boshart M., Weih F., Schmidt A., Fournier R. E., Schütz G. A cyclic AMP response element mediates repression of tyrosine aminotransferase gene transcription by the tissue-specific extinguisher locus Tse-1. Cell. 1990 Jun 1;61(5):905–916. doi: 10.1016/0092-8674(90)90201-o. [DOI] [PubMed] [Google Scholar]
  5. Chibani J., Vidaud M., Duquesnoy P., Bergé-Lefranc J. L., Pirastu M., Ellouze F., Rosa J., Goossens M. The peculiar spectrum of beta-thalassemia genes in Tunisia. Hum Genet. 1988 Feb;78(2):190–192. doi: 10.1007/BF00278196. [DOI] [PubMed] [Google Scholar]
  6. Dörk T., Wulbrand U., Richter T., Neumann T., Wolfes H., Wulf B., Maass G., Tümmler B. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum Genet. 1991 Aug;87(4):441–446. doi: 10.1007/BF00197165. [DOI] [PubMed] [Google Scholar]
  7. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Green P. M., Montandon A. J., Bentley D. R., Ljung R., Nilsson I. M., Giannelli F. The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res. 1990 Jun 11;18(11):3227–3231. doi: 10.1093/nar/18.11.3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hall C. V., Jacob P. E., Ringold G. M., Lee F. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet. 1983;2(1):101–109. [PubMed] [Google Scholar]
  10. Hargrove J. L., Scoble H. A., Mathews W. R., Baumstark B. R., Biemann K. The structure of tyrosine aminotransferase. Evidence for domains involved in catalysis and enzyme turnover. J Biol Chem. 1989 Jan 5;264(1):45–53. [PubMed] [Google Scholar]
  11. Hashimoto S., Schmid W., Schütz G. Transcriptional activation of the rat liver tyrosine aminotransferase gene by cAMP. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6637–6641. doi: 10.1073/pnas.81.21.6637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huisman T. H., Brown A. K., Efremov G. D., Wilson J. B., Reynolds C. A., Uy R., Smith L. L. Hemoglobin Savannah (B6(24) beta-glycine is greater than valine): an unstable variant causing anemia with inclusion bodies. J Clin Invest. 1971 Mar;50(3):650–659. doi: 10.1172/JCI106535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jantzen H. M., Strähle U., Gloss B., Stewart F., Schmid W., Boshart M., Miksicek R., Schütz G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell. 1987 Apr 10;49(1):29–38. doi: 10.1016/0092-8674(87)90752-5. [DOI] [PubMed] [Google Scholar]
  14. Kida K., Takahashi M., Fujisawa Y., Matsuda H., Machino H., Miki Y. Hepatic tyrosine aminotransferase in tyrosinaemia type II. J Inherit Metab Dis. 1982;5(4):229–230. doi: 10.1007/BF02179149. [DOI] [PubMed] [Google Scholar]
  15. Killary A. M., Fournier R. E. A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells. Cell. 1984 Sep;38(2):523–534. doi: 10.1016/0092-8674(84)90507-5. [DOI] [PubMed] [Google Scholar]
  16. Latham T., Grabowski G. A., Theophilus B. D., Smith F. I. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990 Jul;47(1):79–86. [PMC free article] [PubMed] [Google Scholar]
  17. Lemonnier F., Charpentier C., Odievre M., Larregue M., Lemonnier A. Tyrosine aminotransferase isoenzyme deficiency. J Pediatr. 1979 Jun;94(6):931–932. doi: 10.1016/s0022-3476(79)80222-x. [DOI] [PubMed] [Google Scholar]
  18. McKnight S. L., Gavis E. R., Kingsbury R., Axel R. Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell. 1981 Aug;25(2):385–398. doi: 10.1016/0092-8674(81)90057-x. [DOI] [PubMed] [Google Scholar]
  19. Natt E., Scherer G. EMBL 12, a new lambda replacement vector with sites for SalI, XbaI, BamHI, SstI and EcoRI. Nucleic Acids Res. 1986 Sep 11;14(17):7128–7128. [PMC free article] [PubMed] [Google Scholar]
  20. Natt E., Westphal E. M., Toth-Fejel S. E., Magenis R. E., Buist N. R., Rettenmeier R., Scherer G. Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II. Hum Genet. 1987 Dec;77(4):352–358. doi: 10.1007/BF00291426. [DOI] [PubMed] [Google Scholar]
  21. Rettenmeier R., Natt E., Zentgraf H., Scherer G. Isolation and characterization of the human tyrosine aminotransferase gene. Nucleic Acids Res. 1990 Jul 11;18(13):3853–3861. doi: 10.1093/nar/18.13.3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ruppert S., Boshart M., Bosch F. X., Schmid W., Fournier R. E., Schütz G. Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genes. Cell. 1990 Jun 1;61(5):895–904. doi: 10.1016/0092-8674(90)90200-x. [DOI] [PubMed] [Google Scholar]
  23. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schmid E., Schmid W., Jantzen M., Mayer D., Jastorff B., Schütz G. Transcription activation of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur J Biochem. 1987 Jun 15;165(3):499–506. doi: 10.1111/j.1432-1033.1987.tb11467.x. [DOI] [PubMed] [Google Scholar]
  25. Schmid W., Scherer G., Danesch U., Zentgraf H., Matthias P., Strange C. M., Röwekamp W., Schütz G. Isolation and characterization of the rat tryptophan oxygenase gene. EMBO J. 1982;1(10):1287–1293. doi: 10.1002/j.1460-2075.1982.tb00026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Westphal E. M., Burmeister M., Wienker T. F., Lehrach H., Bender K., Scherer G. Tyrosine aminotransferase and chymotrypsinogen B are linked to haptoglobin on human chromosome 16q: comparison of genetic and physical distances. Genomics. 1987 Dec;1(4):313–319. doi: 10.1016/0888-7543(87)90030-9. [DOI] [PubMed] [Google Scholar]
  27. Westphal E. M., Natt E., Grimm T., Odievre M., Scherer G. The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II. Hum Genet. 1988 Jul;79(3):260–264. doi: 10.1007/BF00366248. [DOI] [PubMed] [Google Scholar]
  28. Wullich B., Natt E., Wienker T. F., Scherer G. A BAM HI RFLP at the human tyrosine aminotransferase (TAT) gene locus at 16q. Nucleic Acids Res. 1989 Apr 25;17(8):3331–3331. doi: 10.1093/nar/17.8.3331. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES